Better Health, Brighter Future
The Company’s purpose is to provide “Better Health for People, Brighter Future for the World.” In line with this purpose, the Company is pursuing a management framework appropriate for a values-based R&D-driven biopharmaceutical company that operates on a global scale. We are strengthening internal controls, thorough compliance and risk management, and establishing a structure that will allow agile decision-making that is also sound and transparent. Through these efforts, we will further improve our corporate governance, thereby maximizing corporate value.
|JULY 11, 2022 Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange|
|JUNE 29, 2022 Takeda Announces New Assignments of Directors|
|JUNE 29, 2022 Takeda updates Skill Matrix|
|NOVEMBER 1, 2021 Takeda published Corporate Governance related Documents on its website|